The Vanguard Group 13D/13G Filings for Phathom Pharmaceuticals, Inc. (PHAT)

The Vanguard Group 13D and 13G filings for Phathom Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2023-02-09
11:30 am
Sale
2022-12-30 13G Phathom Pharmaceuticals, Inc.
PHAT
The Vanguard Group 1,076,605
2.590%
-851,239decrease
(-44.15%)
Filing
2022-02-10
08:32 am
Purchase
2021-12-31 13G Phathom Pharmaceuticals, Inc.
PHAT
The Vanguard Group 1,927,844
6.140%
1,927,844increase
(New Position)
Filing